Technical Analysis for ZCOR - Egalet Corp

Grade Last Price % Change Price Change
grade C 2.08 -0.48% -0.0100
ZCOR closed down 0.48 percent on Thursday, October 17, 2019, on 1 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Up
See historical ZCOR trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -0.48%
Wide Bands Range Expansion -0.48%
Gapped Up Strength -0.48%
Overbought Stochastic Strength -0.48%
Narrow Range Bar Range Contraction 4.00%
Stochastic Reached Overbought Strength 4.00%

Older signals for ZCOR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Egalet Corporation, a specialty pharmaceutical company, develops, manufactures, and commercializes treatments for patients with pain and other conditions. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic pain severe enough to require an opioid analgesic, and for which alternative treatments are inadequate; and ARYMO ER, an extended-release (ER) morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The company is also developing Egalet-002, a Guardian Technology AD, ER, oral oxycodone formulation, which is in Phase III clinical trials for the same indication as ARYMO ER. In addition, its other products include Egalet-003, an AD stimulant product candidate; and Egalet-004, an AD, ER hydrocodone-based product candidate. The company has a collaboration and license agreement with Acura Pharmaceuticals, Inc. to commercialize OXAYDO tablets; and Septodont, Inc. to promote SPRIX Nasal Spray. Egalet Corporation was founded in 2010 and is headquartered in Wayne, Pennsylvania.
RTT Euphoriants Pharmaceutical Psychoactive Drugs Chemical Compounds Morphinans Heroin Opioids Morphine Oxycodone Acute And Chronic Pain Analgesic Pain Products Alternative Treatments Hydrocodone Immediate Release Oxycodone Product Morphine Product Nasal Spray Short Term Management Sprix Nasal Spray
Is ZCOR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 3.0
52 Week Low 1.0
Average Volume 15,664
200-Day Moving Average 0.0
50-Day Moving Average 2.202
20-Day Moving Average 1.7566
10-Day Moving Average 1.7333
Average True Range 0.1827
ADX 38.23
+DI 34.2789
-DI 44.7062
Chandelier Exit (Long, 3 ATRs ) 1.9519
Chandelier Exit (Short, 3 ATRs ) 1.5481
Upper Bollinger Band 2.4299
Lower Bollinger Band 1.0833
Percent B (%b) 0.74
BandWidth 76.659456
MACD Line -0.0636
MACD Signal Line -0.1642
MACD Histogram 0.1005
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.0800
Resistance 3 (R3) 2.0800 2.0800 2.0800
Resistance 2 (R2) 2.0800 2.0800 2.0800 2.0800
Resistance 1 (R1) 2.0800 2.0800 2.0800 2.0800 2.0800
Pivot Point 2.0800 2.0800 2.0800 2.0800 2.0800
Support 1 (S1) 2.0800 2.0800 2.0800 2.0800 2.0800
Support 2 (S2) 2.0800 2.0800 2.0800 2.0800
Support 3 (S3) 2.0800 2.0800 2.0800
Support 4 (S4) 2.0800